特集: 調査項目の変更・追加が可能なセミカスタムオーダー型の調査レポート(Lucintel社)はこちら

特集 : 国別の市場調査レポートをお探しの方はこちら

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国の動物用ワクチン産業の分析 (2019~2025年)

China Animal Vaccine Industry Report, 2019-2025

発行 ResearchInChina 商品コード 244386
出版日 ページ情報 英文 173 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.13円で換算しております。
中国の動物用ワクチン産業の分析 (2019~2025年) China Animal Vaccine Industry Report, 2019-2025
出版日: 2020年02月21日 ページ情報: 英文 173 Pages
概要

中国の動物用ワクチン産業は2013年から2017年の間に8%のCAGRで成長しましたが、2018年にはアフリカ豚コレラの発生により2.5%低下しました。2019年には更に5.4%も急落し、112億人民元の規模となっています。他方、食肉需要 (鶏肉・牛肉・羊肉) は着実に拡大しているため、家禽用・牛用・羊用のワクチン需要は増加し続けており、ブタ用ワクチンの需要も間もなく底を打って回復する見込みです。動物用ワクチンには接種義務のあるものと完全に民間にゆだねられているものとがありますが、PPR・PRRS・豚コレラなどのワクチンが接種義務から外されたため、有益な市場を狙った外部からの参入が相次ぐものと思われます。

当レポートでは、中国国内の動物用ワクチンの市場について分析し、全体的な市場構造や競争環境、生産・貿易動向の見通し (今後7年間分)、市場競争環境、分野別の詳細動向、内紙系・外資系企業のプロファイル・業績見通し・事業戦略、今後の市場成長の可能性 (全16社分)、といった情報を取りまとめてお届けいたします。

第1章 動物ワクチンの概要

  • 定義
  • 分類
  • 産業連関構造

第2章 動物ワクチン産業の現状

  • 世界市場
    • 市場規模
    • 市場構造
    • 競争環境
  • 中国市場
    • 市場規模
    • 市場構造
    • 輸出額・輸入額
    • 市場参入障壁
    • 競争環境
    • 市場動向

第3章 中国の動物ワクチン産業の発展環境

  • 政策環境
    • 主要政策
    • 強制予防接種ワクチンの入札システム
  • 社会環境
    • 農業の安定した発展
    • 大規模農業がトレンドに
    • 動物伝染病の頻繁な発生

第4章 中国の動物ワクチン産業の内訳

  • 政府の強制ワクチン
    • FMDワクチン
    • 鳥インフルエンザワクチン
  • 市場指向型ワクチン
    • ブタ熱ワクチン
    • PRRS (豚繁殖・呼吸障害症候群) ワクチン
    • PCV (肺炎球菌) ワクチン
    • ニューカッスル病ワクチン
    • ペット用ワクチン

第5章 主要企業

  • China Animal Husbandry Industry Co., Ltd. (CAHIC)
    • プロファイル
    • 経営状況
    • 収益構造
    • 粗利益率
    • 研究開発 (R&D)
    • 動物用ワクチン事業
    • 将来予測・展望
  • Jinyu Bio-technology
  • Tecon Biology
  • Tech-bank Food
  • Hugeleaf
  • Ringpu Bio-technology
  • Hile Bio-Technology
  • Pulike Biological Engineering, Inc.
  • Shen Lian Biomedical
  • Keqian Biology
  • Winsun Bio-Pharmaceutical
  • その他の企業
    • Yikang Biological
    • Weike Biotechnology
    • Nannong Hi-Tech
    • Sinopharm Animal Health
    • Wens Dahuanong

第6章 サマリーと予測

  • サマリー
  • 市場区分
    • 豚用ワクチン
    • 家禽用ワクチン
    • 牛用・羊用ワクチン
図表

Selected Charts

  • Classification of Animal Health Products
  • Animal Vaccine Types (by Constituent and Feature) and Characteristics
  • Animal Vaccine Industry Chain
  • Classification of Animal Epidemics in China
  • Global Veterinary Biological Product Market Size and YoY Change, 2010-2025E
  • Global Animal Vaccine Consumption Structure, 2018
  • Major M&A Events in Global Animal Health Industry, 2005-2019
  • Profile of Global Animal Health Products Giants
  • Chinese Animal Vaccine Market Size and YoY Change, 2013-2019
  • Chinese Animal Vaccine Market Structure (by Applied Type), 2017-2019
  • China's Animal Vaccine Import and Export Volume, 2009-2019
  • China's Average Animal Vaccine Import and Export Prices, 2009-2019
  • China's Animal Vaccine Import Sources (by Import Value), Jan.-Nov. 2019
  • China's Animal Vaccine Export Destinations (by Export Value), Jan.-Nov.2019
  • Main Regions Which Import Animal Vaccines and Their Share in Import Volume in China, Jan.-Nov.2019
  • Main Regions Which Export Animal Vaccines and Their Share in Export Volume in China, Jan.-Nov.2019
  • Number of Veterinary Vaccine Companies in China, 2009-2017
  • Major Chinese Animal Vaccine Manufacturers, 2018
  • Comparison of Major Chinese Animal Vaccine Manufacturers: Revenue, Net Income and Gross Margin in 2018
  • Competitive Landscape of China Animal Vaccine Industry, 2018
  • Main Cases of Foreign Companies' Arrangements in Chinese Animal Vaccine Industry, 2018-2019
  • Production Capacity and Capacity Utilization of Chinese Animal Vaccine Companies, 2009-2018
  • Mergers and Acquisitions in Chinese Animal Vaccine Industry
  • Number of the New Veterinary Drugs Registered in China, 2014-2018
  • Classification of the New Veterinary Drugs Registered (by Application) in China, 2018
  • New Drug Approval of Major Chinese Animal Vaccine Companies, 2018-2019
  • The Quantity of Live Hogs and Sows in China, 2018-2019
  • Capacity Reduction in Provinces/Municipalities in China as of July 25, 2019
  • Statistical Table for African Swine Fever Epidemic and Deblocking of the Infected Areas in China as of January 16, 2020
  • Progress in Research of Candidate Vaccine for African Swine Fever and Efficacies
  • China's ASF Vaccine R&D Results as of October 2019
  • Major Polices on China Animal Vaccine Industry, 2010-2019
  • Compulsory Immunization Plan of Animal Epidemics in China, 2020
  • Animal Diseases worth Priority Prevention in China, 2012-2020
  • Defects of China's Compulsory Immunization Tender System
  • Direction for China's Compulsory Immunization Tender System Reform
  • Output of Meat, Eggs and Milk in China, 2009-2019
  • China's Meat Product Structure (by Output), 2011-2019
  • Quantity Structure (%) of Live Hog Breeding Farms of Varied Scale in China, 2007-2017
  • Quantity Structure (%) of Broiler Breeding Farms of Varied Scale in China, 2007-2017
  • Overview of Common Animal Epidemics in China
  • China's Animal Vaccine Market Structure (by Sales Method)
  • Development Process of Chinese Compulsory Vaccination Policies
  • Usage of Vaccines by Small and Medium-sized Live Pig Farmers by Product in China (%)
  • Winning Prices of Main Animal Vaccines in China, 2018
  • Market Shares of Governmental Mandatory Vaccines and Market-oriented Vaccines in China, 2013-2019
  • The Frequency of Publicized Aftosa Epidemic by China, 2011-2018
  • Chinese Aftosa Vaccine Market Size, 2016-2019
  • Main Aftosa Vaccines and Brands in China
  • Chinese Aftosa Vaccine Market Structure (by Enterprise), 2017
  • Chinese Poultry Vaccine Market Structure (by Type), 2013-2017
  • Spring Tendering for Avian Influenza Vaccines in Some Provinces/Municipalities in China, 2018-2019
  • Information about Chinese Manufacturers of Recombinant Avian Influenza Virus (H5+H7) 3-valent Inactivated Vaccine
  • Tender-based Prices of 3-valent Inactivated Avian Influenza Vaccine in Some Provinces, China
  • Chinese Hog Cholera Vaccine Market Structure (by Type), 2013-2017
  • History of Compulsory Vaccination for Hog Cholera in China
  • Structure of Vaccines Used by Chinese Farmers (by Type)
  • Number of the Producers of Hog Cholera Vaccines (by Variety) in China
  • Product Categories of Main Chinese Hog Cholera Vaccine Producers
  • Chinese PRRS Vaccine Market Size Estimation, 2015 vs.2020
  • Comparison of Main Chinese PRRS Vaccine Companies by Strength
  • China's Total Output (China-made & Imported) of Porcine Circovirus Type 2 Vaccine, 2015-2019
  • Porcine Circovirus Vaccines and Major Manufacturers
  • Porcine Circovirus Type 2 Vaccine under Clinical Trial in 2018
  • Main Newcastle Disease Combined Vaccines of Chinese Animal Vaccine Companies
  • Age Structure of Pet Keepers in China, 2018
  • Pet Population in China, 2018 (by Type, Units in Ten Thousand)
  • Market Size of Vaccines for Pets and Others in China, 2017-2025E
  • Subsidiaries and Branches of CAHIC
  • Controlling Shareholders of CAHIC
  • CAHIC's Revenue and Net Income, 2009-2019
  • CAHIC's Revenue Breakdown by Product, 2011-2018
  • CAHIC's Revenue Structure by Product, 2011-2018
  • CAHIC's Output, Sales Volume and Inventory, 2016-2018 (10k ml/10k doses, ton)
  • CAHIC's Revenue (by Region), 2011-2018
  • CAHIC's Revenue Structure (by Region), 2011-2018
  • Gross Margin of CAHIC's Main Products, 2011-2018
  • CAHIC's R & D Costs and % of Total Revenue, 2011-2018
  • CAHIC's Animal Vaccine Subsidiaries and Their Products
  • Net Income of Major Animal Vaccine Subsidiaries of CAHIC, 2018-2019H1
  • Revenue from and Gross Margin of Veterinary Vaccines of CAHIC, 2011-2018
  • Revenue from Foot-and-Mouth Disease Vaccine of CAHIC, 2016-2018
  • CAHIC's Varieties/Output/Sales Volume of and Revenue/Net Income from Main Veterinary Vaccines, 2018
  • Winning Prices of CAHIC's Veterinary Vaccines, 2018
  • JinyuBio-technology's Revenue and Net Income, 2009-2019
  • Jinyu Bio-technology's Revenue (by Product), 2011-2018 (Unit: RMB mln)
  • Gross Margin of Jinyu Bio-technology's Main Business, 2010-2018
  • Jinyu Bio-technology's R & D Costs and % of Total Revenue, 2011-2018
  • Animal Vaccine Subsidiaries of Jinyu Bio-technology, 2018
  • Jinyu Bio-technology's Output/Sales Volume/Inventory of Main Vaccines, 2018
  • Jinyu Bio-technology's Revenue from and Gross Margin of Vaccines, 2011-2015
  • Main Reserve Vaccines of Jinyu Bio-technology
  • Revenue and Net Income of Jinyu Baoling, 2012-2019
  • Assets and Net Income of Yangzhou Uni-Bio Pharmaceutical, 2012-2019
  • Jinyu Bio-technology's Revenue and Net Income, 2015-2020E
  • Tecon's Revenue and Net Income, 2009-2019
  • Tecon's Revenue (by Product), 2011-2018
  • Tecon's Revenue Structure (by Product), 2011-2018
  • Tecon's Revenue (by Region), 2011-2019
  • Tecon's Revenue Structure (by Region), 2011-2019
  • Gross Margin of Tecon's Main Products, 2011-2018
  • Tecon's R&D Costs and % of Total Revenue, 2011-2019
  • Tecon's Revenue from Top 5 Clients and % of Total Revenue, 2011-2018
  • Tecon's Procurement from Top 5 Suppliers and % of Total Procurement, 2011-2018
  • Tecon's Animal Vaccine Production Bases and Capacity, 2015
  • Animal Vaccines under Research and Progress of Tecon
  • Tecon's Sales of Animal Vaccines, 2016-2018
  • Revenue and Gross Margin of Animal Vaccines of Tecon, 2011-2018
  • Tecon's Revenue and Net Income, 2015-2020E
  • Tech-bank's Revenue and Net Income, 2009-2019
  • Tech-bank's Revenue (by Product), 2017-2019
  • Tech-bank's Revenue (by Region), 2011-2019
  • Tech-bank's Revenue Structure (by Region), 2011-2019
  • Tech-bank's Gross Margin of Main Products, 2016-2019
  • Tech-bank's R&D Costs and % of Total Revenue, 2011-2019
  • Revenue and Net Income of Animal Vaccines of Chengdu Tech-bank, 2016-2019
  • Hugeleaf's Revenue and Net Income, 2009-2019
  • Hugeleaf's Revenue (by Product), 2011-2018
  • Hugeleaf's Revenue Structure (by Product), 2011-2018
  • Hugeleaf's Revenue (by Region), 2011-2018
  • Hugeleaf's Revenue Structure (by Region), 2011-2018
  • Gross Margin of Hugeleaf's Main Products, 2011-2018
  • Hugeleaf's R&D Costs and % of Total Revenue, 2011-2018
  • Revenue and Net Income of Qingdao Yebio Biological Engineering, 2012-2019
  • Ringpu Bio-technology's Revenue and Net Income, 2009-2019
  • Ringpu Bio-technology's Revenue (by Product), 2011-2018
  • Ringpu Bio-technology's Revenue Structure (by Product), 2011-2018
  • Ringpu Bio-technology's Revenue (by Region), 2012-2018
  • Ringpu Bio-technology's Revenue Structure (by Region), 2012-2018
  • Ringpu Bio-technology's Gross Margin of Main Products, 2011-2018
  • Ringpu Bio-technology's R & D Costs and % of Total Revenue, 2011-2018
  • Varieties of Animal Vaccines Launched by Ringpu Bio-technology, 2014-2019
  • Ringpu Bio-technology's Animal Vaccine Output and Sales Volume (by Product), 2011-2018
  • Sales and Gross Margin of Ringpu Bio-technology's Animal Vaccines (by Product), 2013-2018
  • Ringpu Bio-technology's Animal Vaccine Subsidiaries and Their Operation, 2018
  • Ringpu Bio-technology's Animal Vaccines with New Veterinary Drug Approval Number, 2018-2019
  • Ringpu Bio-technology's New Animal Vaccines with New Veterinary Drug Registration Certificate, 2018-2019
  • Progress in the Ongoing Animal Vaccine Projects of Ringpu Bio-technology as of June 2019
  • Hile Bio's Main Products
  • Hile Bio's Revenue and Net Income, 2011-2019
  • Hile Bio's Revenue Structure (by Product), 2011-2016
  • Hile Bio's Revenue Structure (by Product), 2017-2018
  • Hile Bio's Revenue (by Region), 2011-2017
  • Hile Bio's Revenue (by Region), 2018
  • Gross Margin of Hile Bio's Main Products, 2011-2016
  • Hile Bio's R & D Costs and % of Total Revenue, 2011-2018
  • Hile Bio's Main Animal Vaccines under Development and Investment, 2018
  • Hile Bio's Revenue Structure (by Sales Model), 2017-2018
  • Hile Bio's Output, Sales Volume and Inventory of Veterinary Biological Products, 2017-2018
  • Bid Winning of Hile Bio's Animal Vaccines in the Centralized Drug Tender Procurement, 2018
  • Hile Bio's Animal Vaccine Fundraising Projects, 2014
  • Major Holding and Joint-stock Subsidiaries of Pulike, 2018
  • Main Animal Vaccines of Pulike
  • Pulike's Revenue and Net Income, 2012-2019
  • Sales Model and Revenue of Pulike, 2014-2018
  • Pulike's Revenue (by Product), 2012-2018
  • Pulike's Revenue Structure (by Product), 2012-2018
  • Gross Margin of Pulike's Main Products, 2012-2018
  • Pulike's R & D Costs and % of Total Revenue, 2011-2019
  • Animal Vaccine Output, Sales Volume, and Inventory of Pulike, 2018
  • Output and Sales Volume of Pulike's Main Animal Vaccines, 2018
  • Revenue and Gross Margin of Pulike's Animal Vaccines, 2012-2018
  • Pulike's Investments in R&D OF Main Animal Vaccines, 2018
  • Revenue and Net Income of Shanghai Shen Lian Biomedical, 2016-2019
  • Revenue Structure (by Product) of Shanghai Shen Lian Biomedical, 2019H1
  • Revenue Structure (by Region) of Shanghai Shen Lian Biomedical, 2016-2019H1
  • Gross Margin of Shanghai Shen Lian Biomedical, 2016-2019
  • Shanghai Shen Lian Biomedical's R&D Costs and % of Total Revenue, 2016-2019
  • Top Five Customers of Shanghai Shen Lian Biomedical, 2016-2019
  • Top Five Suppliers of Shanghai Shen Lian Biomedical, 2016-2019
  • Revenue Structure (by Sales Model) of Shanghai Shen Lian Biomedical, 2016-2019H1
  • Quantity Tender and Qualification Tender Winning of Shanghai Shen Lian Biomedical, 2016-2019
  • Sales Volume (by Product) of Shanghai Shen Lian Biomedical, 2016-2019
  • Capacity Utilization and Production & Sales of Shanghai Shen Lian Biomedical, 2016-2019
  • Development Course of Wuhan Keqian Biology
  • Revenue and Net Income of Wuhan Keqian Biology, 2016-2019
  • Operating Revenue (by Product) of Wuhan Keqian Biology, 2016-2019H1
  • Operating Revenue Structure (by Product) of Wuhan Keqian Biology, 2016-2019H1
  • Operating Revenue (by Region) of Wuhan Keqian Biology, 2016-2019H1
  • Operating Revenue Structure (by Region) of Wuhan Keqian Biology, 2016-2019H1
  • Gross Margin (by Product) of Wuhan Keqian Biology, 2016-2019
  • Wuhan Keqian Biology's R&D Costs and % of Total Revenue, 2016-2019
  • Revenue Structure (by Sales Model) of Wuhan Keqian Biology, 2016-2019H1
  • Average Selling Price and Sales Volume of Main Vaccines of Wuhan Keqian Biology, 2016-2019
  • Wuhan Keqian Biology's Revenue from and Sales Volume of Top Five Products, 2016-2019
  • Capacity Planning of Wuhan Keqian Biology's Animal Biological Product Industrialization Project
  • Animal Vaccine Capacity, Output and Sales Volume of Wuhan Keqian Biology, 2016-2019
  • Production Lines of Wuhan Keqian Biology
  • Revenue and Net Income of Guangdong Winsun Bio-Pharmaceutical, 2014-2019
  • Revenue (by Product) of Guangdong Winsun Bio-Pharmaceutical, 2014-2018
  • Revenue Structure (by Product) of Guangdong Winsun Bio-Pharmaceutical, 2014-2018
  • Revenue Structure (by Region) of Guangdong Winsun Bio-Pharmaceutical, 2018
  • Guangdong Winsun Bio-Pharmaceutical's Revenue from Top5 Clients, 2014-2018
  • Guangdong Winsun Bio-Pharmaceutical's Procurement from Top5 Suppliers, 2014-2018
  • Guangdong Winsun Bio-Pharmaceutical's R&D Costs and % of Total Revenue, 2014-2018
  • Animal Vaccine Business Development of Winsun Bio-Pharmaceutical, 2018-2019
  • Chinese Animal Vaccine Market Size and YoY Change, 2013-2025E
  • Chinese Animal Vaccine Market Structure (by Animal Attributes), 2025
  • Chinese Swine Vaccine Market Size, 2013-2025E
  • Chinese Poultry Vaccine Market Size, 2013-2025E
  • Chinese Cattle and Sheep Vaccine Market Size, 2017-2025E
目次

Chinese animal vaccine industry showed a CAGR of 8% between 2013 and 2017, but it was depressed by the outbreak of African Swine Fever in 2018 with the market size edging down 2.5% on an annualized basis. As estimated, the animal vaccine market would plummet by 5.4% and stand at RMB11.2 billion in 2019.

Meanwhile, the demand for poultry meat, beef and mutton rises steadily, so does the vaccines for poultry, cattle and sheep. As ASF vaccines are anticipated to be available on the market in 2020 and the quantity of live hogs picks up, the hog vaccine market will bottom out and begin to rise in the upcoming years, being expectedly worth RMB17.18 billion in 2025.

In China, animal vaccines are mainly for hogs, poultry, cattle and sheep. Yet, the hog vaccine market plunged as a result of the African Swine Fever, triggering an estimated market share down to 28.3% in 2019 when the poultry vaccines would hold a share up to 39.1%.

Animal vaccines fall into the vaccines used for compulsory vaccination and the market-oriented vaccines in China, where the former covers the diseases such as highly pathogenic avian influenza, aftosa, peste des petits ruminants (PPR), Brucellosis, and hydatidosis. Porcine Reproductive and Respiratory Syndrome (PRRS) and hog cholera started to be excluded from compulsory vaccination in 2017, which is conductive to the more lucrative market-priced vaccines for animals.

Chinese animal vaccine industry is currently dominated by homegrown companies like Jinyu Bio-technology, China Animal Husbandry Industry Co., Ltd.(CAHIC), Qingdao Yebio Biological Engineering Co., Ltd. (Yebio), Tecon Biology, Keqian Biology, Ringpu Bio-technology, and Pulike Biological Engineering. Among them, Jinyu Bio-technology is the largest producer of animal vaccines in China, with its revenue in 2018 reporting RMB1,845.5 million and enjoying a 15.6% share of the domestic animal vaccine market.

In addition, the broad prospects of Chinese animal vaccine industry draws attention from foreign companies like MSD and Boehringer Ingelheim, and they have made inroads in the Chinese market through joint ventures, acquisitions and sole proprietaries.

China's animal vaccines are heading towards:

  • i.) The growing concentration of the industry: Chinese animal vaccine producers are now faced with huge overcapacity, low capacity utilization and serious homogenization of products. Some leading Chinese players have staged mergers and acquisitions successively to be more competitive. The industry concentration is on a steady rise.
  • ii.) New products facilitate the development of the industry: In 2018, there were a total of 71 new veterinary drugs in China, including 22 registrations of vaccine new veterinary drugs or a 31% share. The roll-out of vaccine new veterinary drugs is expected to boost the development of the animal vaccine industry;
  • iii.) African Swine Fever brings growth potential: A nosedive in the quantity of live hogs since the outbreak of the African Swine Fever in China in August 2018 leads to a tumble in the hog vaccine market. Breakthroughs have been made by China in vaccination for African Swine Fever. In October 2019, China first isolated the structure of the ASF virus, and pilot production of the ASF vaccine has been fulfilled. The vaccine will be ratified and launched to the market in 2020, significantly invigorating the hog cholera vaccine market.

‘China Animal Vaccine Industry Report, 2019-2025’ highlights the followings:

  • Animal vaccine market in China and beyond (market size & structure, import & export, competitive landscape and development tendencies);
  • Environments (policy climate and social environment) for the development of China's animal vaccine industry;
  • Animal vaccine market segments in China;

16 Chinese animal vaccine companies (operation, revenue structure, gross margin, R&D costs, animal vaccine business, etc.)

Table of Contents

1. Overview of Animal Vaccine

  • 1.1 Definition
  • 1.2 Classification
  • 1.3 Industry Chain

2. Status Quo of Animal Vaccine Industry

  • 2.1 Global Market
    • 2.1.1 Market Size
    • 2.1.2 Market Structure
    • 2.1.3 Competitive Landscape
  • 2.2 Chinese Market
    • 2.2.1 Market Size
    • 2.2.2 Market Structure
    • 2.2.3 Import and Export
    • 2.2.4 Entry Barriers
    • 2.2.5 Competitive Landscape
    • 2.2.6 Trends

3. Development Environment for China Animal Vaccine Industry

  • 3.1 Policy Environment
    • 3.1.1 Major Policies
    • 3.1.2 Tendering System for Compulsory Immunization Vaccine
  • 3.2 Social Environment
    • 3.2.1 Stable Development of Farming Industry
    • 3.2.2 Large-scale Farming Becomes a Trend
    • 3.2.3 Frequent Outbreaks of Animal Epidemics

4. Chinese Animal Vaccine Industry Segments

  • 4.1 Governmental Mandatory Vaccine
    • 4.1.1 FMD Vaccine
    • 4.1.2 Bird Flu Vaccine
  • 4.2 Market-oriented Vaccine
    • 4.2.1 Swine Fever Vaccine
    • 4.2.2 PRRS Vaccine
    • 4.2.3 PCV Vaccine
    • 4.2.4 Newcastle Disease Vaccine
    • 4.2.5 Pet Vaccine

5 Key Enterprises

  • 5.1 China Animal Husbandry Industry Co., Ltd. (CAHIC)
    • 5.1.1 Profile
    • 5.1.2 Operation
    • 5.1.3 Revenue Structure
    • 5.1.4 Gross Margin
    • 5.1.5 R & D
    • 5.1.6 Animal Vaccine Business
  • 5.2 Jinyu Bio-technology
    • 5.2.1 Profile
    • 5.2.2 Operation
    • 5.2.3 Revenue Structure
    • 5.2.4 Gross Margin
    • 5.2.5 R & D
    • 5.2.6 Animal Vaccine Business
    • 5.2.7 Forecast and Outlook
  • 5.3 Tecon Biology
    • 5.3.1 Profile
    • 5.3.2 Operation
    • 5.3.3 Revenue Structure
    • 5.3.4 Gross Margin
    • 5.3.5 R&D
    • 5.3.6 Clients and Suppliers
    • 5.3.7 Animal Vaccine Business
    • 5.3.8 Forecast and Outlook
  • 5.4 Tech-bank Food
    • 5.4.1 Profile
    • 5.4.2 Operation
    • 5.4.3 Revenue Structure
    • 5.4.4 Gross Margin
    • 5.4.5 R&D
    • 5.4.6 Animal Vaccine Business
  • 5.5 Hugeleaf
    • 5.5.1 Profile
    • 5.5.2 Operation
    • 5.5.3 Revenue Structure
    • 5.5.4 Gross Margin
    • 5.5.5 R&D
    • 5.5.6 Animal Vaccine Business
  • 5.6 Ringpu Bio-technology
    • 5.6.1 Profile
    • 5.6.2 Operation
    • 5.6.3 Revenue Structure
    • 5.6.4 Gross Margin
    • 5.6.5 R & D
    • 5.6.6 Animal Vaccine Business
  • 5.7 Hile Bio-Technology
    • 5.7.1 Profile
    • 5.7.2 Operation
    • 5.7.3 Revenue Structure
    • 5.7.4 Gross Margin
    • 5.7.5 R&D
    • 5.7.6 Animal Vaccine Business
  • 5.8 Pulike Biological Engineering, Inc.
    • 5.8.1 Profile
    • 5.8.2 Operation
    • 5.8.3 Revenue Structure
    • 5.8.4 Gross Margin
    • 5.8.5 R&D
    • 5.8.6 Animal Vaccine Business
  • 5.9 Shen Lian Biomedical
    • 5.9.1 Profile
    • 5.9.2 Operation
    • 5.9.3 Revenue Structure
    • 5.9.4 Gross Margin
    • 5.9.5 R&D
    • 5.9.6 Clients and Suppliers
    • 5.9.7 Animal Vaccine Business
  • 5.10 Keqian Biology
    • 5.10.1 Profile
    • 5.10.2 Operation
    • 5.10.3 Revenue Structure
    • 5.10.4 Gross Margin
    • 5.10.5 R&D
    • 5.10.6 Animal Vaccine Business
  • 5.11 Winsun Bio-Pharmaceutical
    • 5.11.1 Profile
    • 5.11.2 Operation
    • 5.11.3 Revenue Structure
    • 5.11.4 Clients and Suppliers
    • 5.11.5 R&D
    • 5.11.6 Animal Vaccine Business
  • 5.12 Other Enterprises
    • 5.12.1 Yikang Biological
    • 5.12.2 Weike Biotechnology
    • 5.12.3 Nannong Hi-Tech
    • 5.12.4 Sinopharm Animal Health
    • 5.12.5 Wens Dahuanong

6. Summary and Forecast

  • 6.1 Summary
  • 6.2 Market Segments
    • 6.2.1 Swine Vaccine
    • 6.2.2 Poultry Vaccine
    • 6.2.3 Cattle and Sheep Vaccine